NVIDIA
NVDA
Tesla
TSLA
Applovin
APP
4
Alibaba
BABA
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
MIST Milestone Pharmaceuticals
- 1.750
- -0.050-2.78%
Close Feb 26 16:00 ET
93.32MMarket Cap-2.19P/E (TTM)
1.850High1.720Low1.35MVolume1.820Open1.800Pre Close2.37MTurnover2.54%Turnover RatioLossP/E (Static)53.33MShares2.75052wk High3.89P/B92.71MFloat Cap1.12052wk Low--Dividend TTM52.98MShs Float27.950Historical High--Div YieldTTM7.22%Amplitude1.120Historical Low1.765Avg Price1Lot Size
Milestone Pharmaceuticals News
Milestone Pharmaceuticals | 8-K: Current report
Milestone Pharmaceuticals | SCHEDULE 13G/A: Others
Milestone Pharmaceuticals | SCHEDULE 13G/A: Others
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nelson Jeffrey Edward
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Oliveto Joseph
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bharucha David
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hasija Amit
Milestone Pharmaceuticals | EFFECT: Others
Milestone Pharmaceuticals | CORRESP: CORRESP
Milestone Pharmaceuticals | UPLOAD: Others
Milestone Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Milestone Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Milestone Pharmaceuticals | 8-K: Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
Milestone Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Milestone Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(5.2%),Millennium Group Management LLC(5.2%), etc.
Milestone Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director PAPA JOSEPH C
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PAPA JOSEPH C
Milestone Pharmaceuticals | 8-K: Current report
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Saik Andrew
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Giles Lisa M.